{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:24:51Z","timestamp":1761164691215,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.tvjl.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T10:41:58Z","timestamp":1555756918000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Questions associated with the development of novel drugs intended for the treatment of bacterial infections in veterinary species"],"prefix":"10.1016","volume":"248","author":[{"given":"Marilyn N.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: can we make evolution-proof drugs?","volume":"12","author":"Allen","year":"2014","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0010","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/ismej.2015.232","article-title":"Quorum sensing protects bacterial co-operation from exploitation by cheats","volume":"10","author":"Allen","year":"2016","journal-title":"The ISME Journal"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mib.2009.06.012","article-title":"Productive steps toward an antimicrobial targeting virulence","volume":"12","author":"Barczk","year":"2009","journal-title":"Current Opinions in Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/187152607780090685","article-title":"Targeting bacterial secretion systems: benefits of disarmament in the microcosm","volume":"7","author":"Baron","year":"2007","journal-title":"Infectious Disorders Drug Targets"},{"issue":"6","key":"10.1016\/j.tvjl.2019.04.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01906-16","article-title":"Siderophores: more than stealing iron","volume":"7","author":"Behnsen","year":"2016","journal-title":"mBio"},{"issue":"Suppl. 136","key":"10.1016\/j.tvjl.2019.04.009_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apm.12099","article-title":"The role of bacterial biofilms in chronic infections","author":"Bjarnsholt","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fm.2014.11.017","article-title":"Campylobacter virulence and survival factors","volume":"48","author":"Bolton","year":"2015","journal-title":"Food Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro1818","article-title":"The biology and future prospects of AV therapies","volume":"6","author":"Cegelski","year":"2008","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev-biochem-062911-102821","article-title":"Structural biology of bacterial Type IV secretion systems","volume":"84","author":"Chandran Darbari","year":"2015","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nchembio.2007.24","article-title":"Targeting virulence: a new paradigm for antimicrobial therapy","volume":"3","author":"Clatworthy","year":"2007","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3780697","article-title":"Bacteriophages and their immunological applications against infectious threats","author":"Criscuolo","year":"2017","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0060","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1209","article-title":"Infectious complications with the use of biologic response modifiers in infants and children","volume":"138","author":"Davies","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tim.2017.10.005","article-title":"Quorum-sensing systems as targets for AV therapy","volume":"26","author":"Defoirdt","year":"2018","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: AV strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/ismej.2014.155","article-title":"Comparative genome analysis and identification of competitive and cooperative interactions in a polymicrobial disease","volume":"9","author":"Endo","year":"2015","journal-title":"The ISME Journal"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jprot.2016.04.006","article-title":"Targeting human pathogenic bacteria by siderophores: a proteomics review","volume":"145","author":"Ferreira","year":"2016","journal-title":"Journal of Proteomics"},{"issue":"1","key":"10.1016\/j.tvjl.2019.04.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0012-2015","article-title":"Bacterial secretion systems: an overview","volume":"4","author":"Green","year":"2016","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri.2016.29","article-title":"The immunology of host defense peptides: beyond antimicrobial activity","volume":"16","author":"Hancock","year":"2016","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/bcp.12356","article-title":"Targeting virulence not viability in the search for future antibacterials","volume":"79","author":"Heras","year":"2015","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chom.2009.12.007","article-title":"A Type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria","volume":"7","author":"Hood","year":"2010","journal-title":"Cell Host and Microbe"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ni1102-1033","article-title":"Bacterial strategies for overcoming host innate and adaptive immune responses","volume":"3","author":"Hornef","year":"2002","journal-title":"Nature Immunology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.foodres.2017.07.077","article-title":"Probiotics as potential alternative biocontrol agents in the agriculture and food industries: A review","volume":"100","author":"Hossain","year":"2017","journal-title":"Food Research International"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0115","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1586\/14787210.2014.976613","article-title":"Antimicrobial peptides: therapeutic potentials","volume":"12","author":"Kang","year":"2014","journal-title":"Expert Review of Anti-infective Therapy"},{"issue":"5","key":"10.1016\/j.tvjl.2019.04.009_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000883","article-title":"Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa","volume":"6","author":"K\u00f6hler","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bbapap.2015.05.001","article-title":"Breaking a pathogen\u2019s iron will: inhibiting siderophore production as an antimicrobial strategy","volume":"1854","author":"Lamb","year":"2015","journal-title":"Biochemica et Biophysica Acta"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0130","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.plasmid.2015.12.001","article-title":"Whole genome sequencing of diverse Shiga toxin-producing and non-producing Escherichia coli strains reveals a variety of virulence and novel antibiotic resistance plasmids","volume":"83","author":"Losada","year":"2016","journal-title":"Plasmid"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0140","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/AAC.42.11.2817","article-title":"Effects of sub-inhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates","volume":"42","author":"Ohlsen","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/MMBR.00078-15","article-title":"Klebsiella pneumoniae: going on the offense with a strong defense","volume":"80","author":"Paczosa","year":"2006","journal-title":"Microbiology and Molecular Biology Reviews"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.mib.2006.08.004","article-title":"Immunomodulators as an antimicrobial tool","volume":"9","author":"Pirofski","year":"2006","journal-title":"Current Opinion in Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/IAI.01216-13","article-title":"Cooperation, quorum sensing, and evolution of virulence in Staphylococcus aureus","volume":"82","author":"Pollitt","year":"2014","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0160","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tim.2013.06.008","article-title":"Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors","volume":"21","author":"Raymond","year":"2013","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/PMC.S13209","article-title":"Interfering with bacterial quorum sensing","volume":"8","author":"Reuter","year":"2016","journal-title":"Perspectives in Medicinal Chemistry"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molimm.2006.06.011","article-title":"Bacterial complement evasion","volume":"44","author":"Rooijakkers","year":"2007","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0175","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ni1528","article-title":"Pathogen subversion of cell-intrinsic innate immunity","volume":"8","author":"Roy","year":"2007","journal-title":"Nature Immunology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/cbdd.12517","article-title":"Virulence-targeted antibacterials: concept, promise, and susceptibility to resistance mechanisms","volume":"86","author":"Ruer","year":"2015","journal-title":"Chemical Biology and Drug Design"},{"issue":"1","key":"10.1016\/j.tvjl.2019.04.009_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/genes8010039","article-title":"The complex relationship between virulence and antibiotic resistance genes","volume":"8","author":"Schroeder","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0190","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12362","article-title":"Bacterial resistance to antimicrobial agents and its impact on veterinary and human medicine","volume":"28","author":"Schwarz","year":"2017","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0195","article-title":"Animal Health Research ReviewsAlternatives to Antibiotics: a Symposium on the Challenges and Solutions for Animal Production2013","author":"Seal","year":"2013","journal-title":"Alternatives to Antibiotics: a Symposium on the Challenges and Solutions for Animal Production"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0200","first-page":"22","article-title":"Current indications for the use of clindamycin: a critical review","volume":"9","author":"Smieja","year":"1998","journal-title":"The Canadian Journal of Infectious Diseases"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/14787210.5.2.271","article-title":"Novel approaches to bacterial infection therapy by interfering with bacteria-to-bacteria signaling","volume":"5","author":"Sperandio","year":"2007","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0210","first-page":"45","article-title":"Trojan horse antibiotics-a novel way to circumvent gram-negative bacterial resistance?","volume":"9","author":"Tillotson","year":"2016","journal-title":"Infectious Diseases (Auckland)"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/2210303106666160506120057","article-title":"Benefits and challenges of AV antimicrobials at the dawn of the post-antibiotic era","volume":"6","author":"Totsika","year":"2016","journal-title":"Drug Delivery Letters"},{"issue":"Suppl. 1","key":"10.1016\/j.tvjl.2019.04.009_bib0220","article-title":"Protein secretion systems in bacterial-host associations, and their description in the gene ontology","volume":"9","author":"Tseng","year":"2009","journal-title":"BMC Microbiology"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0225","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/08927014.2015.1137289","article-title":"Exploiting the AV efficacy of an ajoene-ciprofloxacin combination against Pseudomonas aeruginosa biofilm associated murine acute pyelonephritis","volume":"32","author":"Vadekeetil","year":"2016","journal-title":"Biofouling"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001769","article-title":"Limiting damage during infection: lessons from infection tolerance for novel therapeutics","volume":"12","author":"Vale","year":"2014","journal-title":"PLoS Biol"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/649557","article-title":"Resilience to bacterial infection: difference between species could be due to proteins in serum","volume":"201","author":"Warren","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.tvjl.2019.04.009_bib0240","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/cc7091","article-title":"Bench-to-bedside review: bacterial virulence and subversion of host defences","volume":"12","author":"Webb","year":"2008","journal-title":"Critical Care"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318302922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318302922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:29:32Z","timestamp":1761071372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023318302922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":48,"alternative-id":["S1090023318302922"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2019.04.009","relation":{},"ISSN":["1090-0233"],"issn-type":[{"type":"print","value":"1090-0233"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Questions associated with the development of novel drugs intended for the treatment of bacterial infections in veterinary species","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}